Finance

Lists
Why is MRK up ३.८०%?
Dive Deeper
MRK:NYSE
Merck & Co Inc
US$ १४७.३७
+३.८०%
(+५.३९) 1D
US$ १४८.५०
+०.७७% (+१.१३)
After hours
Closed: अक्टोबर १४, १६:०३:३३ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRK...
Open
US$ १४३.१०
High
US$ १४८.१६
Low
US$ १४२.६६
Mkt. cap
३.६४ खरब
Avg. vol.
९३.३३ लाख
Volume
९८.०८ लाख
Dividend
२.३१%
Quarterly dividend
US$ ०.८५
Ex-dividend date
२०२६ सेप्टेम्बर १५
P/E ratio
११७.७१
52-wk high
US$ १५६.९२
52-wk low
US$ ८२.०१
EPS
US$ १.२५
Beta
०.२१
Shares outstanding
२.४७ अरब
No. of employees
७४ हजार
Open
US$ १४३.१०
High
US$ १४८.१६
Low
US$ १४२.६६
Mkt. cap
३.६४ खरब
Avg. vol.
९३.३३ लाख
Volume
९८.०८ लाख
Dividend
२.३१%
Quarterly dividend
US$ ०.८५
Ex-dividend date
२०२६ सेप्टेम्बर १५
P/E ratio
११७.७१
52-wk high
US$ १५६.९२
52-wk low
US$ ८२.०१
EPS
US$ १.२५
Beta
०.२१
Shares outstanding
२.४७ अरब
No. of employees
७४ हजार
News stories
From web sources and news partners
News Corp
News Corp
·
७ घण्टा पहिले
Lilly, Merck, AbbVie Stocks Surge. Why Healthcare Is Rallying Today.
MarketBeat
MarketBeat
·
९ घण्टा पहिले
Merck & Co., Inc. (NYSE:MRK) Stock Jumps 3.6% - Still a Buy?
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
About Merck & Co Inc
CEORobert M Davis
Employees७४ हजार
Founded१८९१ जनवरी १
Headquarters-
Sector-
Websitemerck.com
Analyst ratings
Based on 21 analysts giving stock ratings to MRK in the past 3 months
Buy
Buy
15
Hold
6
Sell
0
12-month forecast
Based on 21 Wall Street analysts offering 12 month price targets for MRK in the last 3 months.
Highest
Current US$ १४७.३७
US$ १८०.०० (+२२.१४%)
Average
US$ १६०.२४ (+८.७३%)
Lowest
US$ १०५.०० (-२८.७५%)
Analyst
Recommendation
Action
Price target
Projected
Date
Evan Seigerman
BMO Capital
Buy
Maintained
US$ १७०.००
+१५.४%
10/12/2026
Carter Gould
Cantor Fitzgerald
Hold
Maintained
US$ १४५.००
-१.६%
10/11/2026
Daina Graybosch
Leerink Partners
Buy
Maintained
US$ १६१.००
+९.२%
10/12/2026
Trung Huynh
RBC Capital
Hold
Reiterated
US$ १४५.००
-१.६%
10/12/2026
Geoff Meacham
Citi
Hold
Maintained
US$ १४५.००
-१.६%
10/13/2026
Emily Field
Barclays
Buy
Maintained
US$ १५०.००
+१.८%
10/12/2026
Michael Yee
UBS
Buy
Maintained
US$ १७५.००
+१८.७%
10/09/2026
Jason Gerberry
Bank of America Securities
Buy
Maintained
US$ १६३.००
+१०.६%
10/09/2026
Terence Flynn
Morgan Stanley
Buy
Maintained
US$ १७७.००
+२०.१%
10/07/2026
Chris Schott
J.P. Morgan
Buy
Maintained
US$ १६५.००
+१२%
10/05/2026
Asad Haider
Goldman Sachs
Buy
Maintained
US$ १६०.००
+८.६%
09/30/2026
Louise Chen
Scotiabank
Buy
Maintained
US$ १८०.००
+२२.१%
09/29/2026
Steve Scala
TD Cowen
Hold
Maintained
US$ १५५.००
+५.२%
09/22/2026
Nico Chen
DBS
Buy
Maintained
US$ १८०.००
+२२.१%
09/11/2026
Rajesh Kumar
HSBC
Buy
Maintained
US$ १७२.००
+१६.७%
09/10/2026
Vamil Divan
Guggenheim
Buy
Reiterated
US$ १७०.००
+१५.४%
09/08/2026
Courtney Breen
Bernstein
Hold
Maintained
US$ १०५.००
-२८.८%
09/07/2026
Mohit Bansal
Wells Fargo
Buy
Reiterated
US$ १७०.००
+१५.४%
09/04/2026
Jasper Hellweg
Argus Research
Buy
Reiterated
US$ १७०.००
+१५.४%
08/24/2026
Alexandria Hammond
Wolfe Research
Buy
Maintained
US$ १८०.००
+२२.१%
08/25/2026
Luisa Hector
Berenberg Bank
Hold
Maintained
US$ १२७.००
-१३.८%
08/05/2026
Unknown Analyst
Jefferies
Buy
Maintained
US$ १३८.००
-६.४%
05/19/2026
Unknown Analyst
Argus Research
Buy
Reiterated
US$ १३०.००
-११.८%
05/08/2026
Hans Engel
Erste Group
Hold
Maintained
-
-
05/05/2026
Natalya Davies
Rothschild & Co Redburn
Buy
Maintained
US$ १७९.००
+२१.५%
04/17/2026
James Shin
Deutsche Bank
Buy
Upgraded
US$ १५०.००
+१.८%
02/13/2026
Last report
२०२६ अगस्ट ४
Fiscal period
Q2 2026
-US$ ०.१३ / -US$ ०.२६
+४९.४३%beat
Revenue / Est. (USD)
१६.६१ अरब / १६.३७ अरब
+१.४६%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१७.२८ अरब
१६.४० अरब
१६.२९ अरब
१६.६१ अरब
Cost of goods sold
३.७४ अरब
४.३० अरब
३.८८ अरब
४.१३ अरब
Cost of revenue
३.७४ अरब
४.३० अरब
३.८८ अरब
४.१३ अरब
Research and development expenses
४.०० अरब
४.०० अरब
३.५६ अरब
९.७४ अरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.४८ अरब
२.७३ अरब
२.५७ अरब
२.७८ अरब
Operating expense
६.४८ अरब
६.७३ अरब
६.१२ अरब
१२.५२ अरब
Total operating expenses
१०.२३ अरब
११.०२ अरब
१०.०० अरब
१६.६५ अरब
Operating income
७.०५ अरब
५.३८ अरब
६.२९ अरब
-४.०० करोड
Other non operating income
-
४.१० करोड
४.२० करोड
५.९० करोड
EBT including unusual items
६.७४ अरब
३.४२ अरब
-३.५३ अरब
-६८.३० करोड
EBT excluding unusual items
६.७६ अरब
४.९८ अरब
५.८५ अरब
-५०.८० करोड
Income tax expense
९५.८० करोड
४५.८० करोड
७०.९० करोड
६५.४० करोड
Effective tax rate
१४.२०%
१३.३९%
-२०.०६%
-९५.७५%
Other operating expenses
-
-
-
-
Net income
५.७८ अरब
२.९६ अरब
-४.२४ अरब
-१.३४ अरब
Net profit margin
३३.४९%
१८.०७%
-२६.०३%
-८.०४%
Earnings per share
२.५८
२.०४
-१.२८
-०.१३
Interest and investment income
९.६० करोड
६.९० करोड
३.५० करोड
३.५० करोड
Interest expense
-३२.७० करोड
-४१.१० करोड
-४७.९० करोड
-५२.५० करोड
Net interest expenses
-२३.१० करोड
-३४.२० करोड
-४४.४० करोड
-४९.०० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
८.१५ अरब
६.७९ अरब
७.६९ अरब
१.४३ अरब
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू